from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2525c/-

LFCtreatmentdescriptionclass of inhibitor

-0.459

Amikacinug/mL Amikacintranslation

0.748

Cap5-10ug/mL Capreomycintranslation

0.147

Rox10-50 ug/mL Roxithromycintranslation

0.192

SM2-5 ug/mL Streptomycintranslation

-0.895

Tet5-10 ug/mL Tetracyclinetranslation

-0.801

Rif0.2-5ug/mL Rifampicintranscription

-0.437

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.787

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.798

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.303

CPZ10-50 ug/mL Chlorpromazinerespiration

0.031

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.066

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.444

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.258

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.266

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.300

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.053

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.169

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.104

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.486

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.081

KCN5-20 ug/mL Potassium cyaniderespiration

-0.272

NaN30.2-2 mM Sodium aziderespiration

0.441

Nigericin50 uM Nigericinrespiration

-0.148

TRC10-150 ug/mL Triclosanrespiration

0.329

TRZ10-25 ug/mL Thioridazinerespiration

-1.170

Valinomycin0.5-10 uM Valinomycinrespiration

0.326

ZnSO42 mM ZnSO4respiration

-0.293

menadione6-10 ug/mL Menadionerespiration

-2.178

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.027

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.723

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.245

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.283

NRP_1Non-replicating persistence stage 1dosRassociated

0.925

Amp0.2mg/mL AmpicillincellWall

0.857

Cephalexin20-100 ug/mL CephalexincellWall

0.457

Cerulenin0.32-5 ug/mL CerulenincellWall

0.400

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.558

EMB10-20 ug/mL EthambutolcellWall

1.280

Eta12-40 ug/mL EthionamidecellWall

1.529

INH0.2-0.4 ug/mL IsoniazidcellWall

0.453

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.753

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.066

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.502

BZA0.12 mg/mL BenzamidearomaticAmides

-0.301

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.203

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.795

H2O24 mM hydrogen peroxideDNAdamaging

-0.033

Levo10 ug/mL LevofloxacinDNAdamaging

-0.696

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.025

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.782

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.295

UVUV-irradiationDNAdamaging

-0.495

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.991

Antimycin12.5-50 ug/mL Antimycin A?

0.702

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.692

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.393

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.336

PA8240.2-2 ug/mL PA-824?

1.044

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.070

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.486

Verapamil50 uM Verapamil?

-0.230

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.013

methoxatin10-20 ug/mL Methoxatin?